The largest holder of Revvity stock is T. Rowe Price Investment Management, Inc., with 18.3 million shares (16.37% of the company), worth about $2.35 billion as of September 25, 2026. The 10 largest holders together own 69.8%.
In Q2 2026, 562 institutional holdings reports listed shares worth $12.80 billion.
Insiders reported 53 transactions in the last two years: 13 sales worth $9.76 million and no purchases. The newest one on file is from May 7, 2026 (Michas Alexandros P, Director).
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through May 7, 2026.

2026Q2
| Holder | Shares | % of company | Value |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 18.3 million | 16.37% | $2.4B |
| T. Rowe Price Investment Management, Inc. | 10.3 million | 9.20% | $1.3B |
| Janus Henderson Investors US LLC | 8.6 million | 7.74% | $1.1B |
| Edgepoint Investment Group, Inc. | 8.5 million | 7.66% | $1.1B |
| Vanguard Capital Management LLC | 7.3 million | 6.54% | $939.0M |
| BlackRock Advisors LLC | 6.5 million | 5.87% | $842.0M |
| T. Rowe Price International Ltd. | 5.5 million | 4.96% | $712.0M |
| Vanguard Portfolio Management LLC | 4.8 million | 4.28% | $614.0M |
| State Street Corporation | 4.3 million | 3.89% | $559.0M |
| Victory Capital Management, Inc. (Investment Management) | 3.6 million | 3.27% | $469.0M |
As of September 25, 2026.
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 562 | – | $12.8B |
| Q1 2026 | 517 | 115.0 million | $10.1B |
| Q4 2025 | 526 | – | $12.6B |
| Q3 2025 | 538 | 115.0 million | $10.1B |
| Q2 2025 | 555 | 115.0 million | $11.1B |
| Q1 2025 | 544 | 114.0 million | $12.1B |
| Q4 2024 | 553 | 112.0 million | $12.5B |
| Q3 2024 | 548 | 110.0 million | $14.0B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Michas Alexandros P | May 7, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Barrett Peter | May 7, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Witz Pascale | May 7, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Klobuchar Michael A | May 7, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Mcmurry-Heath Michelle | May 7, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Witney Franklin R. Ph.D. | May 7, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Vandebroek Sophie V | May 7, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Vounatsos Michel Pericles | May 7, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Chapin Samuel R. | May 7, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Gonzales Anita | Apr 20, 2026 | Officer | Sale at price 92.80 per share. | $7,424 |
| Gonzales Anita | Mar 16, 2026 | Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Gonzales Anita | Mar 6, 2026 | Officer | Stock Award(Grant) at price 0.00 per share. | – |
Newest 12 of 53 insider transactions in the last two years.
T. Rowe Price Investment Management, Inc., with 16.37% of the company (as of September 25, 2026). Next: T. Rowe Price Investment Management, Inc. (9.20%) and Janus Henderson Investors US LLC (7.74%).
562 institutional holdings reports listed Revvity shares in Q2 2026 worth $12.80 billion.
In the last two years insiders reported 13 sales and no purchases (53 transactions in all); the newest on file is from May 7, 2026.